Clearmind agrees to convert $600,000 notes into common shares at $0.3 each

• Clearmind Medicine set terms to convert USD 600,000 of outstanding Convertible Notes into common shares.
• The parties agreed to a fixed conversion price of USD 0.3 per share, overriding the notes’ conversion-price formula.
• The conversion implies issuance of 2,000,000 common shares, subject to rounding under the notes.
• The Floor Price definition in the form of Convertible Note under the securities purchase agreement was amended to USD 0.3 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-058713), on May 19, 2026, and is solely responsible for the information contained therein.